ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the appointment of Charles (Chuck) J. Bramlage to the position of President, Pharmaceutical Products, effective immediately.
